Indeed, intermediate ATXN2 repeats are also a risk factor for ALS patients with C9orf72 HRE (17) and a possible modifier of disease phenotypes (clinical type and age of onset) of HRE carriers (29) with conflicting evidence. Here, ATXN2 is linked to amyotrophic lateral sclerosis.